发明名称 |
PHARMACEUTICAL COMPOSITION COMPRISING 3-BETA-HYDROXY-17-(1-H-BENZIMIDAZOLE-1-YL)ANDROSTA-5,16-DIENE |
摘要 |
<p>Described are steroidal C-17 benzoazoles, pyrimidinoazoles (azabenzoazoles) and diazines. Methods for their synthesis are also described, which include methods having a step of nucleophilic vinylic "addition-elimination" substitution reaction of 3²-acetoxy-17-chloro-16-formylandrosta-5,16-diene or analogs thereof and benzoazole or pyrimidinoazole nucleophiles and methods having a palladium catalyzed cross-coupling reaction of 17-iodoandrosta-5,16-dien-3²-ol or analogs thereof with tributylstannyl diazines. The compounds are potent inhibitors of human CYP 17 enzyme as well as potent antagonists of both wild type and mutant androgen receptors (AR). The compounds are useful for the treatment of human prostate cancer.</p> |
申请公布号 |
SI2206719(T1) |
申请公布日期 |
2015.03.31 |
申请号 |
SI20060031883T |
申请日期 |
2006.03.02 |
申请人 |
UNIVERSITY OF MARYLAND, BALTIMORE |
发明人 |
BRODIE ANGELA;NJAR VINCENT |
分类号 |
|
主分类号 |
|
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|